Pharmafile Logo

Claire Long

- PMLiVE

Open Health merges with med comms services provider Peloton

The combined entity will fall under the Open Health brand

- PMLiVE

Diagnosed Anywhere

What’s wrong? Increasingly, technology-driven tools have the answer

Live from Singapore: Oncology in APAC – Evaluating the opportunity for novel therapies

Live webinar: Tuesday 11th December 2018,16:00 SGT / 17:00 JST

Inizio

- PMLiVE

Right intervention, right tool

'Don't start with the solution, start with the problem'

- PMLiVE

GSK buys cancer firm Tesaro for $5.1bn

Acquisition re-establishes US commercial operations in oncology

- PMLiVE

Digital applications are transforming the market access landscape

Optimising product value through digital technology

- PMLiVE

Amgen’s BCMA drug on course to challenge CAR-Ts in myeloma

BiTE will rival therapies from Bluebird, Celgene/Juno, J&J/Legend biotech

- PMLiVE

Grail to initiate largest ever UK cancer screening study

Will start testing on 50,000 people in early 2019

- PMLiVE

New models of NHS care – new models of pharma response?

At PME and IQVIA’s roundtable event, leaders discuss how industry needs to adapt to help an NHS undergoing transformational change

- PMLiVE

Video – The importance of efficient ideas

With the right idea, video is a powerful tool within any industry, with the wrong idea it can become a time-consuming money sponge. An efficient idea is a must.

Page & Page Health

- PMLiVE

Regeneron’s early stage bispecific shows promise

Bispecifics and antibody drug conjugates will challenge CAR-Ts

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links